Case Study | September 09, 2011

Compassionate Care & Confident Results with Hologic Breast Biopsy Technology

Frederick Memorial Hospital, Frederick, Maryland

Compassionate Care & Confident Results with Hologic Breast Biopsy Technology

The combination of the MultiCare table and the Eviva device makes a significant difference for the patient experience during stereotactic biopsies.

Sponsored by Hologic Inc.

Frederick Memorial Hospital (FMH) was the first healthcare provider in Frederick County, Maryland, to offer digital mammography with the addition of Hologic Selenia digital mammography. In 2010, FMH once again partnered with Hologic for breast biopsy technology at its state-of-the-art women’s center – a partnership that has led to greater patient comfort and efficiency without sacrificing diagnostic confidence.

A New Era of Women’s Health
With the opening of its newest outpatient facility, FMH Crestwood, FMH has embarked on a new era in women’s health services. Every detail of the Women’s Center at Crestwood – from the interior design to the comprehensive services available – focuses on patient comfort and care.

With a private, women-only imaging suite, patients have access to a full complement of state-of-the-art imaging services from screening to treatment in a single location, including digital mammography, breast ultrasound, breast biopsies and MRI. Onsite radiologists are available to review mammograms before patients leave, meaning follow-up procedures can be scheduled immediately, often on the same day.

According to Director of Imaging Brent Purscelley, technology plays a big role in FMH’s ability to offer this level of comprehensive and coordinated service. By partnering with Hologic for its technology needs, FMH was able to improve comfort, accuracy and efficiency of breast biopsy procedures.

Better Access & Improved Comfort for Stereotactic Procedures
For stereotactic breast biopsy procedures, FMH utilizes the Hologic MultiCare Platinum prone stereotactic breast biopsy system with an Eviva vacuum-assisted breast biopsy device. The automated coordinates of the MultiCare Platinum table provide efficiency and precision, ensuring accurate targeting and easy access to a majority of lesions.

To address patient comfort, FMH upgraded the table in 2010 with the addition of the MultiCare Maximum Comfort Package, a collection of ergonomically engineered cushions designed to provide targeted pressure point support for most body types and lesions.

“The design of the table and the addition of the Comfort Package give us greater flexibility in the types of patients we are able to accommodate with minimally-invasive stereotactic biopsy procedures,” says Radiologist and Chief of FMH Mammography Services Peter Kremers, M.D. “From an accessibility standpoint, it has made a significant difference in terms of being able to sample more hard-to-reach lesions, particularly in the posterior portion of the breast. From a comfort standpoint, it has been a huge improvement for our patients.”

The Eviva device combines quiet pneumatic firing and end-deploy site marking into a fully integrated system for stereotactic breast biopsy. The design for continuous delivery of pain medication to the biopsy site significantly improves comfort without interrupting the procedure. In addition, the forward firing motion of the needle improves accuracy and enables radiologists to more effectively sample lesions.

“In the past, patients would often report experiencing pain during breast biopsies, but that rarely happens now,” says Mary Abercrombie, a biopsy technologist at FMH Crestwood. “The combination of the MultiCare table and the Eviva device makes a significant difference for the patient experience during stereotactic biopsies.”

Diagnostic Confidence with Ultrasound and MRI Biopsies
FMH also utilizes the Hologic ATEC breast biopsy and excision system for ultrasound- and MRI-guided biopsies, as well as the Celero breast biopsy device for handheld, ultrasound-guided biopsies.

According to Dr. Kremers, the ATEC system is faster and produces larger cores than other systems. With a one-time needle insertion and a fully enclosed system with a dedicated collection chamber, the ATEC system also contributes to a faster, more efficient process by automatically collecting samples throughout the procedure.

“I think there’s both a time and cost savings on the back end when you’re not having to pull out individual samples as they’re acquired,” he says. “It also makes the process of x-raying the specimens after collection much smoother. Overall, the ATEC system just makes for a more efficient procedure.”

The Celero breast biopsy device provides radiologists with an ultrasound-guided breast biopsy option that produces large consistent cores, meaning fewer insertions than other devices are needed to obtain an accurate diagnosis. The lightweight handpiece is easy to maneuver, making it easy to sample even hard-to-reach lesions. The device’s trocar tip also enables the needle to fire in a straight line, which Dr. Kremers says is particularly helpful when trying to sample very dense lesions.  

“Over the years there has been a trend of pathologists and physicians asking for more definitive diagnoses, which has led to a gradual increase in core sample sizes,” Dr. Kremers says. “Our Hologic equipment has given us the ability to obtain high quality tissue samples that more than meets this expectation.”

The comments included in this article are the opinions and personal stories of the individuals quoted and not necessarily those of Hologic.
Hologic, ATEC, Celero, Eviva, MultiCare and Selenia are trademarks and/or registered trademarks of Hologic Inc. and/or its subsidiaries in the United States and/or other countries.

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing...